Systemic Therapy for Melanoma: ASCO Guideline
Year: 2020
Type: article
Source: Journal of Clinical Oncology
DOI: 10.1200/jco.20.00198
Authors: Rahul Seth, Hans Messersmith, Varinder Kaur, John M. Kirkwood, Ragini Kudchadkar, Jennifer Leigh McQuade, Anthony Provenzano, Umang Swami, Jeffrey Weber, Krishna C. Alluri, Sanjiv Agarwala, Paolo A. Ascierto, Michael B. Atkins, Nancy Davis, Marc S. Ernstoff, Mark B. Faries, Jason S. Gold, Samantha Guild, David E. Gyorki, Nikhil I. Khushalani, Michael O. Meyers, Caroline Robert, Mario Santinami, Amikar Sehdev, Vernon K. Sondak, Gilliosa Spurrier, Katy K. Tsai, Alexander van Akkooi, Pauline Funchain
Institutions: SUNY Upstate Medical University, American Society of Clinical Oncology, University of Virginia, University of Pittsburgh, UPMC Hillman Cancer Center, University of Pittsburgh Medical Center, Emory University, The University of Texas MD Anderson Cancer Center, University of Utah, Huntsman Cancer Institute, NYU Langone Health, NYU Langone’s Laura and Isaac Perlmutter Cancer Center, New York University, St. Luke's Mountain States Tumor Institute, Temple University, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Georgetown Lombardi Comprehensive Cancer Center, Vanderbilt University Medical Center, Roswell Park Comprehensive Cancer Center, Cedars-Sinai Medical Center, Angeles Clinic and Research Institute, VA Boston Healthcare System, AIM at Melanoma Foundation, Peter MacCallum Cancer Centre, Moffitt Cancer Center, University of North Carolina at Chapel Hill, Université Paris-Saclay, Institut Gustave Roussy, Fondazione IRCCS Istituto Nazionale dei Tumori, Indiana University School of Medicine, University of California, San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center, The Netherlands Cancer Institute, Cleveland Clinic
Language: English
Topic: Melanoma and MAPK Pathways
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W3013646646